[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pulmonary Function Testing Systems Market Size, Manufacturers, Opportunities and Forecast to 2030

April 2024 | 106 pages | ID: G280A195802FEN
APO Research

US$ 3,450.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function.

The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease.

According to APO Research, The global Pulmonary Function Testing Systems market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

Global Pulmonary Function Testing Systems main players are CareFusion(BD), Schiller, MGC Diagnostics, M&B, etc. Global top five manufacturers hold a share about 50%. Europe is the largest market, with a share about 30.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pulmonary Function Testing Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Function Testing Systems.

The Pulmonary Function Testing Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pulmonary Function Testing Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • CareFusion(BD)
  • Schiller
  • CHEST
  • COSMED
  • nSpire Health
  • NDD
  • MGC Diagnostics
  • Minato
  • Ganshorn
  • AESRI
  • Morgan Scientific
  • M&B
  • Sikeda
  • RSDQ
Pulmonary Function Testing Systems segment by Type
  • Portable PFT Systems
  • Complete PFT Systems
Pulmonary Function Testing Systems segment by Application
  • Hospitals
  • Physical Examination Center
  • Physician Groups
  • Others
Pulmonary Function Testing Systems Segment by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Function Testing Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Function Testing Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Function Testing Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pulmonary Function Testing Systems manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pulmonary Function Testing Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Global Market Growth Prospects
  1.2.1 Global Pulmonary Function Testing Systems Market Size Estimates and Forecasts (2019-2030)
  1.2.2 Global Pulmonary Function Testing Systems Sales Estimates and Forecasts (2019-2030)
1.3 Pulmonary Function Testing Systems Market by Type
  1.3.1 Portable PFT Systems
  1.3.2 Complete PFT Systems
1.4 Global Pulmonary Function Testing Systems Market Size by Type
  1.4.1 Global Pulmonary Function Testing Systems Market Size Overview by Type (2019-2030)
  1.4.2 Global Pulmonary Function Testing Systems Historic Market Size Review by Type (2019-2024)
  1.4.3 Global Pulmonary Function Testing Systems Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
  1.5.1 North America Pulmonary Function Testing Systems Sales Breakdown by Type (2019-2024)
  1.5.2 Europe Pulmonary Function Testing Systems Sales Breakdown by Type (2019-2024)
  1.5.3 Asia-Pacific Pulmonary Function Testing Systems Sales Breakdown by Type (2019-2024)
  1.5.4 Latin America Pulmonary Function Testing Systems Sales Breakdown by Type (2019-2024)
  1.5.5 Middle East and Africa Pulmonary Function Testing Systems Sales Breakdown by Type (2019-2024)

2 GLOBAL MARKET DYNAMICS

2.1 Pulmonary Function Testing Systems Industry Trends
2.2 Pulmonary Function Testing Systems Industry Drivers
2.3 Pulmonary Function Testing Systems Industry Opportunities and Challenges
2.4 Pulmonary Function Testing Systems Industry Restraints

3 MARKET COMPETITIVE LANDSCAPE BY COMPANY

3.1 Global Top Players by Pulmonary Function Testing Systems Revenue (2019-2024)
3.2 Global Top Players by Pulmonary Function Testing Systems Sales (2019-2024)
3.3 Global Top Players by Pulmonary Function Testing Systems Price (2019-2024)
3.4 Global Pulmonary Function Testing Systems Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Pulmonary Function Testing Systems Key Company Manufacturing Sites & Headquarters
3.6 Global Pulmonary Function Testing Systems Company, Product Type & Application
3.7 Global Pulmonary Function Testing Systems Company Commercialization Time
3.8 Market Competitive Analysis
  3.8.1 Global Pulmonary Function Testing Systems Market CR5 and HHI
  3.8.2 Global Top 5 and 10 Pulmonary Function Testing Systems Players Market Share by Revenue in 2023
  3.8.3 2023 Pulmonary Function Testing Systems Tier 1, Tier 2, and Tier

4 PULMONARY FUNCTION TESTING SYSTEMS REGIONAL STATUS AND OUTLOOK

4.1 Global Pulmonary Function Testing Systems Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Pulmonary Function Testing Systems Historic Market Size by Region
  4.2.1 Global Pulmonary Function Testing Systems Sales in Volume by Region (2019-2024)
  4.2.2 Global Pulmonary Function Testing Systems Sales in Value by Region (2019-2024)
  4.2.3 Global Pulmonary Function Testing Systems Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Pulmonary Function Testing Systems Forecasted Market Size by Region
  4.3.1 Global Pulmonary Function Testing Systems Sales in Volume by Region (2025-2030)
  4.3.2 Global Pulmonary Function Testing Systems Sales in Value by Region (2025-2030)
  4.3.3 Global Pulmonary Function Testing Systems Sales (Volume & Value), Price and Gross Margin (2025-2030)

5 PULMONARY FUNCTION TESTING SYSTEMS BY APPLICATION

5.1 Pulmonary Function Testing Systems Market by Application
  5.1.1 Hospitals
  5.1.2 Physical Examination Center
  5.1.3 Physician Groups
  5.1.4 Others
5.2 Global Pulmonary Function Testing Systems Market Size by Application
  5.2.1 Global Pulmonary Function Testing Systems Market Size Overview by Application (2019-2030)
  5.2.2 Global Pulmonary Function Testing Systems Historic Market Size Review by Application (2019-2024)
  5.2.3 Global Pulmonary Function Testing Systems Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
  5.3.1 North America Pulmonary Function Testing Systems Sales Breakdown by Application (2019-2024)
  5.3.2 Europe Pulmonary Function Testing Systems Sales Breakdown by Application (2019-2024)
  5.3.3 Asia-Pacific Pulmonary Function Testing Systems Sales Breakdown by Application (2019-2024)
  5.3.4 Latin America Pulmonary Function Testing Systems Sales Breakdown by Application (2019-2024)
  5.3.5 Middle East and Africa Pulmonary Function Testing Systems Sales Breakdown by Application (2019-2024)

6 COMPANY PROFILES

6.1 CareFusion(BD)
  6.1.1 CareFusion(BD) Comapny Information
  6.1.2 CareFusion(BD) Business Overview
  6.1.3 CareFusion(BD) Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2019-2024)
  6.1.4 CareFusion(BD) Pulmonary Function Testing Systems Product Portfolio
  6.1.5 CareFusion(BD) Recent Developments
6.2 Schiller
  6.2.1 Schiller Comapny Information
  6.2.2 Schiller Business Overview
  6.2.3 Schiller Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2019-2024)
  6.2.4 Schiller Pulmonary Function Testing Systems Product Portfolio
  6.2.5 Schiller Recent Developments
6.3 CHEST
  6.3.1 CHEST Comapny Information
  6.3.2 CHEST Business Overview
  6.3.3 CHEST Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2019-2024)
  6.3.4 CHEST Pulmonary Function Testing Systems Product Portfolio
  6.3.5 CHEST Recent Developments
6.4 COSMED
  6.4.1 COSMED Comapny Information
  6.4.2 COSMED Business Overview
  6.4.3 COSMED Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2019-2024)
  6.4.4 COSMED Pulmonary Function Testing Systems Product Portfolio
  6.4.5 COSMED Recent Developments
6.5 nSpire Health
  6.5.1 nSpire Health Comapny Information
  6.5.2 nSpire Health Business Overview
  6.5.3 nSpire Health Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2019-2024)
  6.5.4 nSpire Health Pulmonary Function Testing Systems Product Portfolio
  6.5.5 nSpire Health Recent Developments
6.6 NDD
  6.6.1 NDD Comapny Information
  6.6.2 NDD Business Overview
  6.6.3 NDD Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2019-2024)
  6.6.4 NDD Pulmonary Function Testing Systems Product Portfolio
  6.6.5 NDD Recent Developments
6.7 MGC Diagnostics
  6.7.1 MGC Diagnostics Comapny Information
  6.7.2 MGC Diagnostics Business Overview
  6.7.3 MGC Diagnostics Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2019-2024)
  6.7.4 MGC Diagnostics Pulmonary Function Testing Systems Product Portfolio
  6.7.5 MGC Diagnostics Recent Developments
6.8 Minato
  6.8.1 Minato Comapny Information
  6.8.2 Minato Business Overview
  6.8.3 Minato Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2019-2024)
  6.8.4 Minato Pulmonary Function Testing Systems Product Portfolio
  6.8.5 Minato Recent Developments
6.9 Ganshorn
  6.9.1 Ganshorn Comapny Information
  6.9.2 Ganshorn Business Overview
  6.9.3 Ganshorn Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2019-2024)
  6.9.4 Ganshorn Pulmonary Function Testing Systems Product Portfolio
  6.9.5 Ganshorn Recent Developments
6.10 AESRI
  6.10.1 AESRI Comapny Information
  6.10.2 AESRI Business Overview
  6.10.3 AESRI Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2019-2024)
  6.10.4 AESRI Pulmonary Function Testing Systems Product Portfolio
  6.10.5 AESRI Recent Developments
6.11 Morgan Scientific
  6.11.1 Morgan Scientific Comapny Information
  6.11.2 Morgan Scientific Business Overview
  6.11.3 Morgan Scientific Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2019-2024)
  6.11.4 Morgan Scientific Pulmonary Function Testing Systems Product Portfolio
  6.11.5 Morgan Scientific Recent Developments
6.12 M&B
  6.12.1 M&B Comapny Information
  6.12.2 M&B Business Overview
  6.12.3 M&B Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2019-2024)
  6.12.4 M&B Pulmonary Function Testing Systems Product Portfolio
  6.12.5 M&B Recent Developments
6.13 Sikeda
  6.13.1 Sikeda Comapny Information
  6.13.2 Sikeda Business Overview
  6.13.3 Sikeda Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2019-2024)
  6.13.4 Sikeda Pulmonary Function Testing Systems Product Portfolio
  6.13.5 Sikeda Recent Developments
6.14 RSDQ
  6.14.1 RSDQ Comapny Information
  6.14.2 RSDQ Business Overview
  6.14.3 RSDQ Pulmonary Function Testing Systems Sales, Revenue and Gross Margin (2019-2024)
  6.14.4 RSDQ Pulmonary Function Testing Systems Product Portfolio
  6.14.5 RSDQ Recent Developments

7 NORTH AMERICA BY COUNTRY

7.1 North America Pulmonary Function Testing Systems Sales by Country
  7.1.1 North America Pulmonary Function Testing Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  7.1.2 North America Pulmonary Function Testing Systems Sales by Country (2019-2024)
  7.1.3 North America Pulmonary Function Testing Systems Sales Forecast by Country (2025-2030)
7.2 North America Pulmonary Function Testing Systems Market Size by Country
  7.2.1 North America Pulmonary Function Testing Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  7.2.2 North America Pulmonary Function Testing Systems Market Size by Country (2019-2024)
  7.2.3 North America Pulmonary Function Testing Systems Market Size Forecast by Country (2025-2030)

8 EUROPE BY COUNTRY

8.1 Europe Pulmonary Function Testing Systems Sales by Country
  8.1.1 Europe Pulmonary Function Testing Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  8.1.2 Europe Pulmonary Function Testing Systems Sales by Country (2019-2024)
  8.1.3 Europe Pulmonary Function Testing Systems Sales Forecast by Country (2025-2030)
8.2 Europe Pulmonary Function Testing Systems Market Size by Country
  8.2.1 Europe Pulmonary Function Testing Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  8.2.2 Europe Pulmonary Function Testing Systems Market Size by Country (2019-2024)
  8.2.3 Europe Pulmonary Function Testing Systems Market Size Forecast by Country (2025-2030)

9 ASIA-PACIFIC BY COUNTRY

9.1 Asia-Pacific Pulmonary Function Testing Systems Sales by Country
  9.1.1 Asia-Pacific Pulmonary Function Testing Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  9.1.2 Asia-Pacific Pulmonary Function Testing Systems Sales by Country (2019-2024)
  9.1.3 Asia-Pacific Pulmonary Function Testing Systems Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Pulmonary Function Testing Systems Market Size by Country
  9.2.1 Asia-Pacific Pulmonary Function Testing Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  9.2.2 Asia-Pacific Pulmonary Function Testing Systems Market Size by Country (2019-2024)
  9.2.3 Asia-Pacific Pulmonary Function Testing Systems Market Size Forecast by Country (2025-2030)

10 LATIN AMERICA BY COUNTRY

10.1 Latin America Pulmonary Function Testing Systems Sales by Country
  10.1.1 Latin America Pulmonary Function Testing Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  10.1.2 Latin America Pulmonary Function Testing Systems Sales by Country (2019-2024)
  10.1.3 Latin America Pulmonary Function Testing Systems Sales Forecast by Country (2025-2030)
10.2 Latin America Pulmonary Function Testing Systems Market Size by Country
  10.2.1 Latin America Pulmonary Function Testing Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  10.2.2 Latin America Pulmonary Function Testing Systems Market Size by Country (2019-2024)
  10.2.3 Latin America Pulmonary Function Testing Systems Market Size Forecast by Country (2025-2030)

11 MIDDLE EAST AND AFRICA BY COUNTRY

11.1 Middle East and Africa Pulmonary Function Testing Systems Sales by Country
  11.1.1 Middle East and Africa Pulmonary Function Testing Systems Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  11.1.2 Middle East and Africa Pulmonary Function Testing Systems Sales by Country (2019-2024)
  11.1.3 Middle East and Africa Pulmonary Function Testing Systems Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Pulmonary Function Testing Systems Market Size by Country
  11.2.1 Middle East and Africa Pulmonary Function Testing Systems Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
  11.2.2 Middle East and Africa Pulmonary Function Testing Systems Market Size by Country (2019-2024)
  11.2.3 Middle East and Africa Pulmonary Function Testing Systems Market Size Forecast by Country (2025-2030)

12 VALUE CHAIN AND SALES CHANNELS ANALYSIS

12.1 Pulmonary Function Testing Systems Value Chain Analysis
  12.1.1 Pulmonary Function Testing Systems Key Raw Materials
  12.1.2 Key Raw Materials Price
  12.1.3 Raw Materials Key Suppliers
  12.1.4 Manufacturing Cost Structure
  12.1.5 Pulmonary Function Testing Systems Production Mode & Process
12.2 Pulmonary Function Testing Systems Sales Channels Analysis
  12.2.1 Direct Comparison with Distribution Share
  12.2.2 Pulmonary Function Testing Systems Distributors
  12.2.3 Pulmonary Function Testing Systems Customers

13 CONCLUDING INSIGHTS

14 APPENDIX

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
  14.5.1 Secondary Sources
  14.5.2 Primary Sources
14.6 Disclaimer


More Publications